FELICIA PEREZ CANEZ: Open Payments
NPI 1801149331 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$157 in 8 payments from 5 companies in 2025. Trend: 2023 $762 · 2024 $480 · 2025 $157
Food & beverage: $157
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $65 |
| Alkermes, Inc. | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
Products named: CAPLYTA, ARISTADA, COBENFY, INVEGA SUSTENNA, INGREZZA.
Industry payments across AZ — which companies pay providers there.
